STEPHEN TOOVEY - 31 Dec 2023 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Role
Director
Signature
/s/ Stephen Toovey
Issuer symbol
SXTP
Transactions as of
31 Dec 2023
Transactions value $
$892
Form type
4
Filing time
21 May 2024, 20:23:00 UTC
Previous filing
11 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SXTP Common Stock Award $892 +4,000 +40% $0.223 14,000 16 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SXTP Restricted Stock Units Award $0 +4,000 $0 4,000 31 Dec 2023 Common Stock 4,000 $0 Direct F2
transaction SXTP Restricted Stock Units Options Exercise $0 -4,000 -50% $0 4,000 16 May 2024 Common Stock 4,000 $0 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the settlement of restricted stock units in shares of common stock on May 16, 2024.
F2 Stephen Toovey was initially granted a total of 8,000 restricted stock units ("RSUs") on July 11, 2023, of which were subsequently modified effective as of December 31, 2023 to 4,000 RSUs which were fully vested as of December 31, 2023.
F3 4,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 4,000 RSUs, Stephen Toovey did not own any RSUs.